{"adverse_reactions":["Sincerus Florida, LLC. Adverse reactions c"],"components":["Active, inactive d"],"effective_time":"20190509","id":"887acc18-5f42-5c4d-e053-2995a90ae103","instructions_for_use":["Directions for use s"],"openfda":{},"package_label_principal_display_panel":["NDC 72934-1157-2 NIACINAMIDE USP 4% / SPIRONOLACTONE USP 5%. Gel 30gm. s"],"set_id":"887acc18-5f41-5c4d-e053-2995a90ae103","spl_product_data_elements":["NIACINAMIDE 4% / SPIRONOLACTONE 5% NIACINAMIDE 4% / SPIRONOLACTONE 5% NIACINAMIDE NIACINAMIDE SPIRONOLACTONE SPIRONOLACTONE"],"version":"1"}